17-1650803-C-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM4PP5_Moderate
The NM_006445.4(PRPF8):c.7007G>C(p.Ter2336SerextTer41) variant causes a stop lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
PRPF8
NM_006445.4 stop_lost
NM_006445.4 stop_lost
Scores
1
6
Clinical Significance
Conservation
PhyloP100: 2.02
Genes affected
PRPF8 (HGNC:17340): (pre-mRNA processing factor 8) Pre-mRNA splicing occurs in 2 sequential transesterification steps. The protein encoded by this gene is a component of both U2- and U12-dependent spliceosomes, and found to be essential for the catalytic step II in pre-mRNA splicing process. It contains several WD repeats, which function in protein-protein interactions. This protein has a sequence similarity to yeast Prp8 protein. This gene is a candidate gene for autosomal dominant retinitis pigmentosa. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Stoplost variant in NM_006445.4 Downstream stopcodon found after 7 codons.
PP5
Variant 17-1650803-C-G is Pathogenic according to our data. Variant chr17-1650803-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 1066917.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr17-1650803-C-G is described in Lovd as [Pathogenic]. Variant chr17-1650803-C-G is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRPF8 | NM_006445.4 | c.7007G>C | p.Ter2336SerextTer41 | stop_lost | 43/43 | ENST00000304992.11 | |
PRPF8 | XM_024450537.2 | c.7007G>C | p.Ter2336SerextTer41 | stop_lost | 43/43 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRPF8 | ENST00000304992.11 | c.7007G>C | p.Ter2336SerextTer41 | stop_lost | 43/43 | 1 | NM_006445.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 03, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the PRPF8 protein. Other variant(s) that result in a similarly extended protein product (p.*2336Trpext*41) have been determined to be pathogenic (PMID: 26496393). This suggests that these extensions are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1066917). This protein extension has been observed in individuals with clinical features of retinitis pigmentosa (PMID: 31630094, 33576794; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change disrupts the translational stop signal of the PRPF8 mRNA. It is expected to extend the length of the PRPF8 protein by 41 additional amino acid residues. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
N;N
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.